The Current Ratio as of December 2025 (TTM) for Curanex Pharmaceuticals Inc Common Stock (CURX) is 77.53

According to Curanex Pharmaceuticals Inc Common Stock’s latest financial reports and current stock price. The company's current Current Ratio is 77.53. This represents a change of 146.04% compared to the average of 31.51 of the last 4 quarters.

Curanex Pharmaceuticals Inc Common Stock (CURX) Historical Current Ratio (quarterly & annually)

How has CURX Current Ratio performed in the past?

The mean historical Current Ratio of Curanex Pharmaceuticals Inc Common Stock over the last ten years is 13.58. The current 77.53 Current Ratio has changed 56.99% with respect to the historical average. Over the past ten years (40 quarters), CURX's Current Ratio was at its highest in in the June 2024 quarter at 1.11K. The Current Ratio was at its lowest in in the December 2023 quarter at 0.

Curanex Pharmaceuticals Inc Common Stock (CURX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Curanex Pharmaceuticals Inc Common Stock Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Curanex Pharmaceuticals Inc Common Stock (CURX) Average Current Ratio

How has CURX Current Ratio performed in the past?

The current Current Ratio of Curanex Pharmaceuticals Inc Common Stock (CURX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Curanex Pharmaceuticals Inc Common Stock (CURX) Current Ratio vs. Peers

How is CURX’s Current Ratio compared to its peers?

Curanex Pharmaceuticals Inc Common Stock’s Current Ratio is greater than Pulmatrix, Inc. (19.97), greater than Aspire Biopharma Holdings, Inc. (0.17), greater than Palisade Bio, Inc. (1.96), greater than Longeveron Inc. (2.09), greater than Hoth Therapeutics, Inc. (27.57), greater than Curis, Inc. (0.70), greater than Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (0.27), greater than Leap Therapeutics, Inc. (1.34), greater than Daré Bioscience, Inc. (1.18), greater than BriaCell Therapeutics Corp. (3.41),

Build a custom stock screener for Curanex Pharmaceuticals Inc Common Stock (CURX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Curanex Pharmaceuticals Inc Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Curanex Pharmaceuticals Inc Common Stock (CURX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Curanex Pharmaceuticals Inc Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.